5-FU |
5-Fluorouracil |
LDH |
Lactate dehydrogenase |
ACEI |
Angiotensin-converting enzyme inhibitor |
LPs |
Lipid peroxides |
AMPK |
Adenosine 5‘-monophosphate -activated protein kinase |
LSD1 |
Lysine-specific demethylase 1 |
ANT |
Anthracycline |
MAPK |
p38-mitogen-activated protein kinase |
ARE |
Anti-oxidant reactive elements |
MDA |
Malondialdehyde |
Bak |
BCL2 antagonist/killer |
MDM2 |
Murine double minute2 |
Bax |
BCL2 associated X |
MMTV |
Mouse mammary tumor virus |
Bcl-2 |
B-cell lymphoma-2 |
mPTP |
Mitochondrial permeability transition pore |
Ca2+
|
Calcium ions |
mTOR |
Mammalian target of rapamycin |
[Ca2+]i
|
Intracellular Ca2+ concentration |
MTX |
Methotrexate |
CaMKII |
Calcium/calmodulin-dependent protein kinase II |
NADH |
Nicotinamide adenine dinucleotide |
CAR T-cell |
Chimeric antigen receptor T cell |
ncRNA |
Non-coding RNA |
CAT |
Catalase |
NF-κB |
Nuclear factor-kappa B |
CD68 |
Cluster of differentiation 68 |
NOX2 |
Nicotinamide adenine dinucleotide phosphate oxidase 2 |
CircITCH |
CircRNA generated from several exons of itchy E3 ubiquitin protein ligase |
NRF-1 |
Nuclear respiratory factor-1 |
CK |
Creatine kinase |
Nrf2 |
NF-E2-related factor 2 |
CK-MB |
Creatine kinase-MB |
NT-proBNP |
Natriuretic peptide |
CoQ10 |
Coenzyme Q10 |
PD-1 |
Programmed death protein-1 |
CP |
Cyclophosphamide |
PD-L1 |
Programmed death-ligand 1 |
CTLA-4 |
Cytotoxic T lymphocyte antigen-4 |
Pgc1 |
Peroxisome proliferator activated receptor gamma coactivator 1 |
Cul3 |
Cullin 3 |
PI3Kγ/Akt |
Phosphoinositide 3-kinase gamma/protein kinase B |
Cyto c |
Cytochrome c |
PINK1 |
PTEN-induced kinase 1 |
DDR |
DNA damage response |
PTEN |
Phosphatase and tensin homolog |
DOX |
Doxorubicin |
PyMT |
Polyoma middle T-antigen |
eNOS |
Endothelial nitric oxide synthase |
Rac1 |
Ras-related C3 botulinum toxin substrate 1 |
ER |
Endoplasmic reticulum |
Raf/MEK |
MAP kinse-ERK kinase |
ERK |
Extracellular signal-regulated kinase |
RE-LY |
Randomized Evaluation Long-Term Anticoagulant Therapy Study |
FBAL |
α-Fluoro-β-alanine |
ROS |
Reactive oxygen species |
FoxO3a |
Forkhead box O3a |
RSV |
Resveratrol |
GOT |
Glutamate oxaloacetate transaminase |
RyR2 |
Ryanodin receptor-2 |
GPT |
Glutamic-pyruvic transaminase |
S6K1 |
Ribosomal protein S6 kinase 1 |
GPx4 |
Glutathione peroxidase 4 |
SESN2 |
Sestrin2 |
GR |
Glutathione reductase |
SMAD2/3 |
Suppressor of mothers against decapentaplegic 2/3 |
GSH |
Glutathione |
SOD |
Superoxide dismutase |
GSK-3β |
Glycogen synthase kinase-3 beta |
SR |
Sarcoplasmic reticulum |
GSTP1 |
Glutathione S-transferase pi 1 |
ST18 |
Suppression of tumorigenicity 18 |
HDAC2 |
Histone deacetylase 2 |
TAC |
Transverse aortic constriction |
HER2 |
Human epidermal growth factor receptor 2 |
TCA cycle |
Tricarboxylic acid cycle |
HF |
Heart failure |
TCM |
Traditional Chinese medicine |
HO-1 |
Heme oxygenase-1 |
TGF-β |
Transforming growth factor-beta |
hs-CRP |
High-sensitivity C-reactive protein |
TKIs |
Tyrosine kinase inhibitors |
ICIs |
Immune-checkpoint inhibitors |
TLR9 |
Toll-like receptor-9 |
IGF-1R |
Insulin-like growth factor 1 receptor |
TMYXP |
Tongmai Yangxin pill |
IL-6 |
Interleukin-6 |
TNF-α |
Tumor necrosis factor alpha |
ING5 |
The inhibitor of growth 5 |
Top2 |
Topoisomerase type 2 |
JNK |
Janus kinase |
TP53 |
Tumor protein p53 |
K48 |
Lysine 48 |
Ulk-1 |
Unc-51-like autophagy activating kinase 1 |
KDM3A |
Lysine-specific histone demethylase 3A |
VEGF-A |
vascular endothelial growth factor A |
Keap1 |
Kelch-like ECH-associated protein 1 |
VigiBase |
Global Individual Case Safety Report database of the World Health Organization |
LC3 |
Light chain 3 |
ZGCT |
Zhigancaotang |